Prognostication for Uveal Melanoma: Are Two Tests Better than One?

Over the last 2 decades, several prognostic tests have been developed for assisting clinicians to predict the metastatic potential of uveal melanoma, including fluorescence in situ hybridization (FISH), comparative genomic hybridization, microsatellite analysis, single-nucleotide polymorphism array (SNP), multiplex ligation-dependent probe amplification (MLPA), and gene expression profiling (GEP) [1]